Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 1g, 0.25g, 5g, 0.1g, 10g, 25g
- Available purity: >95%
- Inventory rows with stock: 6
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 359-25-1
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 1g |
>95% |
5
In Stock
|
Shenzhen |
Inquiry |
| 0.25g |
>95% |
3
In Stock
|
Shanghai |
Inquiry |
| 5g |
>95% |
3
In Stock
|
Shanghai |
Inquiry |
| 0.1g |
>95% |
2
In Stock
|
Beijing |
Inquiry |
| 10g |
>95% |
1
In Stock
|
Shenzhen |
Inquiry |
| 25g |
>95% |
1
In Stock
|
Beijing |
Inquiry |
359-25-1 / 2-bromo-2-fluoroacetic acid
Standard CAS: 359-25-1
Multi CAS: No
Basic Information
CAS
359-25-1
Multi CAS
No
Molecular Formula
BC2H2O2Rf
Molecular Weight
156.940000
Exact Mass
155.922220
InChI
InChI=1S/C2H2BrFO2/c3-1(4)2(5)6/h1H,(H,5,6)
InChIKey
ICTXGKNZADORBH-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
6
Fraction Csp3
0.5
Rotatable bonds
1
H-bond acceptors
1
H-bond donors
1
Molar refractivity
21.46
TPSA
37.3
LogP / Solubility
WLOGP
0.76
MLOGP
0.66
XLogP3
1.1
Consensus LogP
0.84
Log S (ESOL)
-1.23
Class (ESOL)
Soluble
Log S (Ali)
-1.4
Class (Ali)
Soluble
Log S (SILICOS-IT)
-1.43
Class (SILICOS-IT)
Soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.14
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
2